Freshara Agro Exports Ltd Q1 FY27 Earnings Analysis

- FY27 revenue guidance is about ₹575 crores (₹375 crores standalone + ₹200 crores from Sarasa, Spain). - Sarasa’s current capacity utilization is under 50%; existing capacity can scale up to ₹500 crores turnover. - Plan to increase Sarasa’s capacity utilization to 75-80% by next year (targeting ₹350-400 crores revenue). - Within 3 years, aim to reach full capacity utilization (~₹500 crores) at Sarasa. - Consolidated long-term target revenue is ₹1000 crores. - Growth expected through scaling production, cost optimization, and expanding customer base, especially in Europe. - Produce and sell more value-added products (e.g., cocktail olives, ready-to-cook foods) but not commodity products like olive oil. - Conservative guidance approach to focus on profitable growth.

- FY27 revenue guidance is approximately ₹575 crores, combining standalone business and Sarasa contribution. - Sarasa (Spain entity) expected to contribute ₹200 crores in FY27, growing gradually to 50-60% capacity utilization this year. - Sarasa’s margins expected to improve from current 4-5% to around 8-10%, with PAT margin guidance around 10-11%. - Plans to scale Sarasa capacity to 75-80% utilization in FY28, targeting ₹350-400 crores revenue. - Further expansion to 100% capacity (₹500 crores turnover) anticipated within 3 years. - Consolidated long-term target is ₹1000 crores revenue. - Growth to be profitable and cautious, focusing on stable margins and cost-effective strategies. - No major capex required due to existing scalable infrastructure. - Margins expected to improve with operational optimizations and scaling of European operations.

- No major capex of ₹150 crore or more planned currently (Page 15). - Existing production units have capacity to scale up to ₹500 crore without large capex; gradual scaling preferred (Page 20, 23). - Some minor capex to accommodate premium customers and add production lines as required (Page 20). - Focus on optimization and cost management at Sarasa before expanding capacity utilization beyond 50-60% this year (Page 23). - Plans to scale Sarasa capacity utilization to 75-80% next year and eventually up to 100% within three years (Page 23). - Funding for Sarasa acquisition partly through internal accruals, warrants, and bank funding; future working capital likely to be raised through Spanish banks due to good track record (Page 19). - No timeline given for launching new products in India; prioritizing global markets first (Page 18).

- The company funded the Sarasa acquisition partly through internal accruals (about 25%), warrants (around ₹9.5 crores), and bank funding for stock (₹29-30 crore limit). - For FY27 and near-term growth, the company does not foresee significant funding needs immediately. - Future scaling to ₹500 crore revenue for Sarasa may require additional funds. - The company plans to utilize bank credit facilities in Spain for working capital as Sarasa has a profitable balance sheet and good credit history. - No mention of large new equity fundraising; focus is on internal accruals and bank debt for expansion and working capital. - Capex requirements are expected to be moderate and funded gradually with no large immediate capital expenditure planned. In summary, Freshara Agro Exports Limited anticipates using existing credit lines and internal accruals, with possible additional debt in Spain for working capital; no major equity raises planned imminently.

- The company expects the order book to be equivalent to current levels, emphasizing it is the stock of the future. - Q4 (December to March) accounts for about 60-65% of total sales. - Sales from December to March alone were over ₹140 crores, all with a 90-day credit period. - Inventory appears high seasonally due to crop arrival and sale patterns but normalizes as sales happen. - The business is generally cash positive for 7-8 months of the year. - The company maintains strategic inventory to avoid supply disruptions during global uncertainties like wars, ensuring customer demands are met year-round.